Cubist Systematic Strategies, LLC Aurinia Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 168,252 shares of AUPH stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

168,252

Previous 20,409 724.4%

Holding current value

$1.42 Million

Previous $149,000 913.42%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$6.75 - $10.44 $997,940 - $1.54 Million	147,843 Added 724.4%	168,252 $1.51 Million
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $108,575 - $149,597	20,409 New	20,409 $149,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $631,874 - $841,022	88,622 New	88,622 $796,000
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $2.2 Million - $2.88 Million	-245,986 Reduced 90.76%	25,038 $242,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $851,647 - $1.62 Million	143,375 Added 112.32%	271,024 $2.97 Million
Q4 2022 Feb 14, 2023	SELL	$4.11 - $8.14 $239,736 - $474,806	-58,330 Reduced 31.36%	127,649 $551,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $1.24 Million - $2.3 Million	185,979 New	185,979 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $2.46 Million - $3.51 Million	-274,374 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $2.76 Million - $6.17 Million	274,374 New	274,374 $3.4 Million
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $38,890 - $56,468	-3,889 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $25,005 - $38,078	2,033 Added 109.54%	3,889 $50,000
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $18,258 - $22,646	1,411 Added 317.08%	1,856 $26,000
Q3 2020 Nov 16, 2020	SELL	$13.19 - $16.66 $333,786 - $421,597	-25,306 Reduced 98.27%	445 $7,000
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $121,940 - $158,297	-8,636 Reduced 25.11%	25,751 $418,000
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $352,447 - $666,976	31,080 Added 939.82%	34,387 $499,000
Q4 2019 Feb 14, 2020	SELL	$3.88 - $21.42 $9,564 - $52,800	-2,465 Reduced 42.71%	3,307 $67,000
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $28,686 - $35,401	5,372 Added 1343.0%	5,772 $31,000
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $167,585 - $186,975	-27,700 Reduced 98.58%	400 $3,000
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $48,480 - $61,120	8,000 Added 39.8%	28,100 $183,000
Q4 2018 Feb 14, 2019	BUY	$5.08 - $6.83 $102,108 - $137,283	20,100 New	20,100 $137,000
Q1 2018 May 15, 2018	SELL	$4.85 - $5.99 $16,839 - $20,797	-3,472 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.53 - $7.09 $15,728 - $24,616	3,472	3,472 $16,000

Others Institutions Holding AUPH

# of Institutions

226

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.2B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Aurinia Pharmaceuticals Inc. Transaction History